Background: In patients with heart failure, poor ejection fraction and estimated severe aortic stenosis because of a reduced aortic valve area (AVA) and low gradients, dobutamine echocardiography (DE) was proposed to distinguish afterload mismatch from primary left ventricular dysfunction. In this setting the feasibility and safety of DE and the outcome following management based on DE results were investigated.
Methods: Forty-eight patients (mean age 73 +/- 9 years; 79% males; AVA 0.7 +/- 0.2 cm2; mean aortic gradient 22 +/- 6 mmHg; ejection fraction 0.28 +/- 0.07; NYHA functional class 2.9 +/- 0.8) underwent DE and were followed up for 24 +/- 21 months. Aortic valve replacement (AVR) was offered to patients with left ventricular contractile reserve (ejection fraction increase > or = 30% at peak DE) and fixed aortic stenosis (AVA increase < or = 0.25 cm2).
Results: DE elicited a left ventricular contractile reserve in 38 patients (79%). Among these, fixed aortic stenosis was present in 28 patients, among whom 19 underwent AVR and 9 declined surgery. The 20 patients without contractile reserve or with relative stenosis (AVA increase > 0.25 cm2) were not considered eligible for surgery. During follow-up, 23 cardiovascular deaths occurred: 2/19 among operated patients, 7/9 among patients who declined surgery and 14/20 among non-eligible patients. Patients with AVR showed a significantly more favorable outcome and improved functional status as compared to the other two groups (NYHA class 1.2 +/- 0.4 vs 2.7 +/- 0.6 at baseline; p < 0.001). Conversely, non-surgical management was the strongest independent predictor of an adverse outcome (relative risk 3.6, 95% confidence interval 1.8-7.3; p < 0.0001).
Conclusions: In patients with heart failure and estimated severe aortic stenosis, DE could identify a subgroup with a left ventricular contractile reserve and fixed aortic stenosis who gained great benefit from AVR. The clinical outcome of patients who were not operated upon was unfavorable.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Transthyretin amyloid cardiomyopathy in aortic stenosis patients scheduled for transcatheter aortic valve implantation.
ESC Heart Fail
March 2025
Department of Cardiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
Aims: The prevalences of aortic stenosis (AS) and transthyretin amyloid cardiomyopathy (ATTR-CM) increase with age. Identification of occult ATTR-CM in patients with AS can help explain out-of-proportion myocardial dysfunction, aid in prognostication and prompt initiation of disease-modifying treatment. Studies have suggested that many patients referred for transcatheter aortic valve implantation (TAVI) have concomitant ATTR-CM, but some have included unverified ATTR-CM in patients with ambiguous scintigrams.
View Article and Find Full Text PDFAortic Dissection: An Unexpected Complication of Transcatheter Aortic Valve Implantation.
Cureus
February 2025
Cardiology, Unidade Local de Saúde (ULS) São João, Porto, PRT.
A 53-year-old female with a medical history of multiple cardiovascular risk factors, alcoholic chronic hepatic disease (Child-Pugh B) with thrombocytopenia, and severe calcified aortic stenosis was admitted for an elective transcatheter aortic valve implantation (TAVI). After the procedure, the patient was hypotensive and unresponsive to fluid challenge, and there was a significant difference in blood pressure between the two arms. The echocardiogram confirmed the normal position and function of the prosthetic valve but was suggestive of aortic dissection.
View Article and Find Full Text PDFRe-ballooning of sealing frame for intraoperative paravalvular leak during rapid deployment aortic valve replacement: a report of two cases.
Gen Thorac Cardiovasc Surg Cases
March 2025
Division of Cardiovascular Surgery, Tohoku University Graduate School of Medicine, Sendai, Miyagi, 980-8574, Japan.
Background: Rapid deployment aortic valve replacement (RDAVR) has been widely adopted, but concerns about postoperative paravalvular leak (PVL) associated with its use remain. PVL is linked to an increased risk of long-term mortality; however, there is no consensus on its treatment.
Case Presentation: Case 1: A 76-year-old female with severe aortic stenosis underwent RDAVR via median sternotomy.
Impact of hypotonic hyponatremia on outcomes in patients undergoing transcatheter aortic valve replacement: a national inpatient sample.
BMC Cardiovasc Disord
March 2025
School of Clinical Medicine, Ningxia Medical University, Yinchuan, Ningxia, China.
Background: Transcatheter aortic valve replacement (TAVR) has emerged as a major therapeutic option for treating aortic stenosis. Hyponatremia is a common electrolyte disorder closely associated with adverse cardiovascular outcomes. However, large-scale studies investigating the impact of hypotonic hyponatremia on outcomes among TAVR patients are lacking.
View Article and Find Full Text PDFPhysician Modified Endografts Achieve Similar Patient Survival and Target Visceral Vessel Related Outcomes to Factory Made Fenestrated Endografts in Treating Complex Aortic Pathology.
Ann Vasc Surg
March 2025
Division of Vascular Surgery and Endovascular Therapy, Loyola University Health System, Loyola University Chicago Stritch School of Medicine. Electronic address:
Objective: The purpose of this study was to conduct a real-world comparison of visceral stent branch related outcomes and patient survival in physician modified endografts (PMEG) versus factory made fenestrated endografts (FMFE).
Methods: After exclusions, 544 PMEG and 1638 FMFE were identified in the Vascular Quality Initiative between 2014 and 2022. The four primary outcomes analyzed with Kaplan Meier (KM) were freedom from mortality, new onset dialysis, visceral ischemia, and visceral stent graft reintervention in follow up.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!